CBT
ABBV icon

CoreFirst Bank & Trust’s AbbVie ABBV Stock Holding History

CoreFirst Bank & Trust’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$816K Sell
3,751
-614
-14% -$136K 0.43% 50
2025
Q4 		$997K Sell
4,365
-58
-1% -$13.2K 0.54% 41
2025
Q3 		$1.02M Hold
4,423
– – 0.55% 38
2025
Q2 		$821K Buy
4,423
+496
+13% +$92.2K 0.46% 50
2025
Q1 		$823K Sell
3,927
-110
-3% -$21.4K 0.53% 46
2024
Q4 		$717K Hold
4,037
– – 0.43% 55
2024
Q3 		$797K Sell
4,037
-15
-0.4% -$2.8K 0.46% 49
2024
Q2 		$695K Sell
4,052
-30
-0.7% -$4.97K 0.47% 55
2024
Q1 		$743K Sell
4,082
-64
-2% -$11K 0.46% 53
2023
Q4 		$643K Sell
4,146
-1,874
-31% -$273K 0.43% 58
2023
Q3 		$897K Sell
6,020
-15
-0.2% -$2.2K 0.64% 38
2023
Q2 		$813K Sell
6,035
-90
-1% -$13.2K 0.57% 40
2023
Q1 		$976K Sell
6,125
-5
-0.1% -$764 0.71% 34
2022
Q4 		$991K Sell
6,130
-17
-0.3% -$2.61K 0.75% 31
2022
Q3 		$825K Buy
6,147
+59
+1% +$8.47K 0.71% 32
2022
Q2 		$932K Sell
6,088
-120
-2% -$18.3K 0.74% 31
2022
Q1 		$1.01M Buy
6,208
+202
+3% +$29.3K 0.69% 36
2021
Q4 		$813K Sell
6,006
-250
-4% -$29.5K 0.53% 47
2021
Q3 		$675K Sell
6,256
-549
-8% -$62.7K 0.47% 52
2021
Q2 		$767K Hold
6,805
– – 0.52% 45
2021
Q1 		$736K Hold
6,805
– – 0.51% 48
2020
Q4 		$729K Buy
+6,805
New +$654K 0.54% 42

Other funds holding ABBV

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

CoreFirst Bank & Trust's ABBV Position: Q1 2026 in Review

CoreFirst Bank & Trust reduced its AbbVie (ABBV) stake by 14% in Q1 2026, selling an estimated $136K and leaving 3,751 shares worth $816K. The position accounts for 0.43% of the portfolio, ranked #50.

CoreFirst Bank & Trust first reported a position in ABBV in Q4 2020 and has held it in 22 quarters since. The position peaked at $1.02M in Q3 2025. 4,078 funds tracked by Wall St. Rank hold ABBV as of Q1 2026.

  • CoreFirst Bank & Trust held 3,751 shares of AbbVie worth $816K as of Q1 2026.
  • CoreFirst Bank & Trust sold 614 AbbVie shares in Q1 2026, an estimated $136K.
  • AbbVie made up 0.43% of CoreFirst Bank & Trust's portfolio in Q1 2026, its #50 holding.
  • CoreFirst Bank & Trust first reported a position in AbbVie in Q4 2020 and has held it in 22 quarters since.
  • CoreFirst Bank & Trust's AbbVie position peaked at $1.02M in Q3 2025.
  • 4,078 funds tracked by Wall St. Rank held AbbVie as of Q1 2026.

Based on CoreFirst Bank & Trust's 13F filing for Q1 2026, filed 3 Jun 2026.